Document Detail

Significance of magnetic resonance angiography-diffusion weighted imaging mismatch in hyperacute cerebral infarction.
MedLine Citation:
PMID:  20851627     Owner:  NLM     Status:  MEDLINE    
Therapeutic results with respect to lesion size were analyzed and compared in patients with hyperacute cerebral infarction with and without major artery lesions on magnetic resonance angiography (MRA) and in those who did and did not receive intravenous (IV) tissue plasminogen activator (t-PA). Of the patients with cerebral infarction who visited the hospital within 3 hours of onset between April 2007 and September 2009, 127 patients with cerebral infarction in the anterior circulation region in whom head magnetic resonance imaging (diffusion-weighted imaging [DWI]) or MRA was performed (81 men and 46 women; mean age, 71 ± 11 years) were enrolled. Major artery lesions (+) were defined as internal carotid artery occlusion and middle cerebral artery (M1/M2 segment) occlusion and ≥50% stenosis. Based on the presence or absence of major artery lesions and the size of DWI lesions, the subjects were divided into 3 groups: MRA-DWI mismatch (+) group [major artery lesion (+) and DWI-ASPECTS ≥6], MRA-DWI mismatch (-) group [major artery lesion (+) and DWI-ASPECTS <6], and major artery lesion (-) group. IV t-PA was given to 21 of the 64 patients in the MRA-DWI mismatch (+) group, to 1 of the 24 patients in the MRA-DWI mismatch (-) group, and to 9 of the 39 patients in the major artery lesion (-) group. In the MRA-DWI mismatch (+) group (n = 64), the median National Institutes of Health Stroke Scale (NIHSS) score on admission was higher in t-PA-treated patients than in t-PA-untreated patients (15 vs 11). The modified Rankin scale (mRS) score at day 90 after onset was more favorable in t-PA-treated patients (0-2 in 10 patients [48%] and 3-6 in 11 patients [52%]) than in t-PA-untreated patients (0-2 in 12 patients [28%] and 3-6 in 31 patients [72%]). After adjusting for admission NIHSS score, there was a significant difference in outcome (mRS score) between t-PA-treated patients (0-2 in 10 patients [48%] and 3-6 in 11 patients [52%]) and t-PA-untreated patients (0-2 in 3 patients [9%] and 3-6 in 29 patients [91%]) (P = .002). In the MRA-DWI mismatch (-) group (n = 24), mRS scores at day 90 after onset were poor in both t-PA-treated (3-6 in 1 patient [100%]) and t-PA-untreated patients (0-2 in 1 patient [4%] and 3-6 in 22 patients [96%]). In the major artery lesion (-) group (n = 39), mRS scores at day 90 after onset were favorable in both t-PA-treated (0-2 in 9 patients [100%]) and t-PA-untreated patients (0-2 in 28 patients [93%] and 3-6 in 2 patients [7%]). When comparing major artery lesions in the MRA-DWI mismatch (+) group, outcomes were more favorable in patients with M1/M2 segment lesions who received t-PA than in those who did not receive t-PA. In the MRA-DWI mismatch (+) group, the prognosis was significantly better for t-PA-treated patients than for t-PA-untreated patients, suggesting that IV t-PA is indicated in patients with MRA-DWI mismatch.
Ichiro Deguchi; Hidetaka Takeda; Daisuke Furuya; Tomohisa Dembo; Harumitsu Nagoya; Yuji Kato; Yasuo Ito; Takuya Fukuoka; Hajime Maruyama; Norio Tanahashi
Related Documents :
25287657 - Circulating micrornas as novel potential biomarkers for early diagnosis of acute stroke...
25185677 - Congenital amegakaryocytic thrombocytopenia: three case reports from patients with diff...
25211147 - The natural history of spinal neurofibromatosis: a critical review of clinical and gene...
25179317 - Usefulness of the uric acid and cha2ds2-vasc score in prediction of left atrial thrombo...
17028857 - Radiological and functional assessment of pulmonary involvement in the rheumatoid arthr...
22677407 - Decreased aortic root elasticity-as a novel systemic manifestation of the pseudoexfolia...
Publication Detail:
Type:  Journal Article     Date:  2010-09-19
Journal Detail:
Title:  Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association     Volume:  21     ISSN:  1532-8511     ISO Abbreviation:  J Stroke Cerebrovasc Dis     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-01-30     Completed Date:  2012-05-24     Revised Date:  2012-08-11    
Medline Journal Info:
Nlm Unique ID:  9111633     Medline TA:  J Stroke Cerebrovasc Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  108-13     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 National Stroke Association. Published by Elsevier Inc. All rights reserved.
Department of Neurology, Saitama Medical University International Medical Center, Saitama, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Disease
Aged, 80 and over
Cerebral Infarction / diagnosis*,  drug therapy,  pathology,  physiopathology
Cerebrovascular Circulation* / drug effects
Diffusion Magnetic Resonance Imaging*
Fibrinolytic Agents / administration & dosage
Infusions, Intravenous
Magnetic Resonance Angiography*
Middle Aged
Middle Cerebral Artery / drug effects,  pathology,  physiopathology*
Patient Selection
Predictive Value of Tests
Thrombolytic Therapy
Time Factors
Tissue Plasminogen Activator / administration & dosage
Treatment Outcome
Reg. No./Substance:
0/Fibrinolytic Agents; EC Plasminogen Activator
Erratum In:
J Stroke Cerebrovasc Dis. 2012 May;21(4):342

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Brachial artery approach for endovascular treatment of posterior circulation intracranial vascular d...
Next Document:  Predictors of percutaneous endoscopic gastrostomy tube placement in patients with severe dysphagia f...